Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Angelini

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Cardiovascular Considerations for Stimulant Class MedicationsPaul Hammerness, Amy Berger, Michael C Angelini, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Implementation of an opioid management initiative by a state Medicaid programMaria M Garcia, Michael C Angelini, Tara Thomas, et al.
Archives of Internal Medicine|March 12, 2008
The anticholinergic risk scale and anticholinergic adverse effects in older personsJames L Rudolph, Marci J Salow, Michael C Angelini, et al.
Drug and Alcohol Dependence|May 19, 2018
A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorderKaren M Clements, Tasmina Hydery, Mark A Tesell, et al.
The Journal of Pain|January 29, 2019
Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017Maria M Garcia, Kimberly Lenz, Bonnie C Greenwood, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2018
An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid PatientsAshley N Chiara, Neha Kashalikar, Thomas C Pomfret, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Cardiovascular Considerations for Stimulant Class MedicationsPaul Hammerness, Amy Berger, Michael C Angelini, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
Implementation of an opioid management initiative by a state Medicaid programMaria M Garcia, Michael C Angelini, Tara Thomas, et al.
Archives of Internal Medicine|March 12, 2008
The anticholinergic risk scale and anticholinergic adverse effects in older personsJames L Rudolph, Marci J Salow, Michael C Angelini, et al.
Drug and Alcohol Dependence|May 19, 2018
A systematic review of community-based interventions to improve oral chronic disease medication regimen adherence among individuals with substance use disorderKaren M Clements, Tasmina Hydery, Mark A Tesell, et al.
The Journal of Pain|January 29, 2019
Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017Maria M Garcia, Kimberly Lenz, Bonnie C Greenwood, et al.
Journal of Managed Care & Specialty Pharmacy|July 31, 2018
An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid PatientsAshley N Chiara, Neha Kashalikar, Thomas C Pomfret, et al.
Pageof 1